C21orf88 Antikörper (AA 1-100) (Biotin)

Produktnummer ABIN1699898

Produktdetails anti-C21orf88 Antikörper (Biotin)

Target: C21orf88 (C21ORF88) (Chromosome 21 Open Reading Frame 88 (C21ORF88))

Bindungsspezifität: AA 1-100

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser C21orf88 Antikörper ist konjugiert mit Biotin

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Homologie: Human

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human C21orf88

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C for 12 months.

Haltbarkeit: 12 months

Details zu C21orf88

Target: C21orf88 (C21ORF88) (Chromosome 21 Open Reading Frame 88 (C21ORF88))

Andere Bezeichnung: C21orf88 (C21ORF88 Produkte)

Synonyme: B3GALT5 antisense RNA 1 antikoerper, B3GALT5-AS1 antikoerper

Hintergrund:

Synonyms: chromosome 21 open reading frame 88, Putative uncharacterized protein C21orf88, CU088_HUMAN.

Background: The smallest of the human chromosomes, 21 makes up about 1.5 % of the human genome. Chromosome 21 contains nearly 300 genes and 47 million base pairs. Down syndrome, also known as trisomy 21, is the disease most commonly associated with chromosome 21. Alzheimer's disease, Jervell and Lange-Nielsen syndrome and amyotrophic lateral sclerosis are also associated with chromosome 21. Translocations are found to occur between chromosome 21 and 8, and chromosome 21 and 12, in certain leukemias. The C21orf88 gene product has been provisionally designated C21orf88 pending further characterization.